John Maraganore
InvestorUnicorn founderFounder at Alnylam · Advisor at Oak HC/FT
Boston, Massachusetts, United States
FoundedAlnylam$31.2B
About
Founding CEO of Alnylam Pharmaceuticals, which he led from 2002-2021, overseeing the development and commercialization of the first RNAi medicines. He is currently CEO of JMM Innovations and serves on numerous biopharma boards; he holds an M.S. and Ph.D. in biochemistry and molecular biology from the University of Chicago.
Likely emails· guessed from name + firm domain, not firm-published
- j•••@alnylam.comreveal90% confident
- j•••@alnylam.comreveal80% confident
Founder at Alnylam
Intro paths
→
In turn, John can intro founders to Alnylam's investors below.
Experience
- Corsera HealthCo-Chief Executive Officercurrent2025 — presentBoston, Massachusetts, United States
- Merida BiosciencesBoard Membercurrent2025 — present
- JEFFRIES FINANCIAL SERVICES LTDSenior Business Advisorcurrent2024 — presentNew York City Metropolitan Area
- City TherapeuticsExecutive Chaircurrent2023 — present
- Omega FundsVenture Partnercurrent2022 — present
- TakedaBoard Membercurrent2022 — present
- Kymera TherapeuticsBoard Membercurrent2022 — present
- Hemab TherapeuticsChairperson of the Boardcurrent2022 — present
- BlackstoneExecutive Advisorcurrent2022 — presentBoston, Massachusetts, United States
- Atlas VentureVenture Partnercurrent2022 — presentCambridge, Massachusetts, United States
- JMM Innovations LLCPrincipal CEOcurrent2022 — presentBoston, Massachusetts, United States
- BeamBoard Membercurrent2021 — present
- RTW Investments, LPExecutive Partnercurrent2022 — presentBoston, Massachusetts, United States
- Aera TherapeuticsChairperson of the Boardcurrent2022 — present
- ARCH Venture PartnersVenture Partnercurrent2021 — presentBoston, Massachusetts, United States
- Biotechnology Innovation OrganizationBoard Membercurrent2006 — present
- Biotechnology Innovation OrganizationChairperson of the Board2017 — 2019
- Rapport TherapeuticsBoard Member2024 — 2025
- Orbital TherapeuticsChairperson of the Board2023 — 2025
- VersanisBoard Member2022 — 2023
- Alnylam PharmaceuticalsChief Executive Officer2002 — 2021Cambridge, MA
- Millennium PharmaceuticalsSenior Vice President, Strategic Product Development2000 — 2002Cambridge, MA
- Millennium PharmaceuticalsManagement Team and Corporate Officer1997 — 2002Cambridge, MA
- Millennium PharmaceuticalsVice President, Mergers, Acquisitions and Strategic Planning1999 — 2000Cambridge, MA
- Millennium PharmaceuticalsGeneral Manager and Founder, Millennium BioTherapeutics, Inc (MBio)1997 — 1999Cambridge, MA
- BiogenDirector of Market and Business Development1995 — 1997Cambridge, MA
- BiogenProgram Executive and Inventor, Hirulog (ANGIOMAX) Research and Development1988 — 1997Cambridge, MA
- BiogenDirector of Biological Research1992 — 1995Cambridge, MA
- BiogenGroup Leader, Thrombosis and Hemostasis Research1991 — 1992Cambridge, MA
- BiogenSenior Scientist1988 — 1991Cambridge, MA
- BiogenScientist II1987 — 1988Cambridge, MA
- Zymogenetics, Inc.Senior Scientist1986 — 1987Seattle, WA
- The Upjohn CompanyVisiting Research Scientist (post-doctoral research)1985 — 1986Kalamazoo, MI
Colleagues at Oak HC/FT
Alana Bremner
Director of Marketing & Communications at Oak HC/FT
Allen Miller
Partner at Oak HC/FT
Alli Kinzel
Marketing Administrative Coordinator at Oak HC/FT
Alper Koper
Investor at Nexus Ventures
Amit Jhawar
Advisor at Oak HC/FT
Andrew Adams
Co-Founder and Managing Partner at Oak HC/FT
Andy Smith
Partner at Oak HC/FT
Anil Aggarwal
Venture Partner at Oak HC/FT
Frequently asked questions
- Who is John Maraganore?
- Founding CEO of Alnylam Pharmaceuticals, which he led from 2002-2021, overseeing the development and commercialization of the first RNAi medicines. He is currently CEO of JMM Innovations and serves on numerous biopharma boards; he holds an M.S. and Ph.D. in biochemistry and molecular biology from the University of Chicago.
- Where does John Maraganore work?
- John Maraganore is Founder of Alnylam and Advisor at Oak HC/FT.
- What companies did John Maraganore found?
- John Maraganore founded Alnylam.
- Where did John Maraganore go to school?
- John Maraganore studied at University of Chicago (Ph.D., Department of Biochemistry and Molecular Biology); University of Chicago (M.S., Department of Biochemistry and Molecular Biology); University of Chicago (B.A., Division of Biological Sciences).
Founder mafias
University of Chicago mafia102
Also came through, then founded or led a company.
Bobby PittmanMaster's degreeFounded Oathafrica +2Sean HarperABFounded TransFS +2Bharat KilaruBachelor of Arts (BA)Founded Verano Health +2Matt KrisiloffFounded Preventive +1Robby YungB.A. cum laudeFounded The Sandbox +1Alexis BorisyBachelor's degreeFounded Foundation Medicine +1
+ 95 more
Atlas Venture mafia13
Also came through, then founded or led a company.
Nessan BerminghamAnalyst - Associate - Principle - PartnerFounded Korro Bio +2Romesh SubramanianEntrepreneur In ResidenceFounded RaNA Therapeutics +2Phillip SamayoaVenture PartnerFounded Generation Bio +2Jason RhodesPartnerFounded Rectifypharma +1Sumit AgarwalAssociateFounded Shape Security +1Kevin BittermanPartnerFounded Editas Medicine
+ 6 more
ARCH Venture Partners mafia12
Also came through, then founded or led a company.
Sean KendallPartnerFounded ロゴマーク：AIRNA +2Keith LendenVenture PartnerFounded Boundless Bio +2Richard HeymanVenture PartnerFounded Architect Therapeutics +1Jay ParrishVenture PartnerFounded ROME Therapeutics +1Jonathan LimVenture PartnerFounded Boundless Bio +1Sabah OneyVenture PartnerFounded Vilya +1
+ 5 more
Oak HC/FT mafia6
Also came through, then founded or led a company.
Orbital Therapeutics mafia4
Also came through, then founded or led a company.
Same school
Also attended University of Chicago349
Mark SusterManaging Partner at Upfront VenturesShardul ShahInvestor at Index VenturesSam BlackmanEntrepreneur in Residence at GV (Google Ventures)Clay FisherInvestor at Spark CapitalJonas CiplickasPrincipal at Scale Venture PartnersJulia Gonzalez SandersPartner and General Counsel at Crosslink Capital
+ 343 more
